US health officials are required to turn away viable donors for an experimental treatment trial that could help patients diagnosed with COVID-19 due to restrictive policies on blood donation from GBT+ men.
The US Food and Drug Administration (FDA) has granted access to utilising blood donations from patients recovering from COVID-19 in order to treat […] The post Doctors reject GBT+ men from participating in COVID-19 treatment trial due to blood donation policies appeared first on GCN.